CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study)
CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study)
Recruiting · NCT06002659 · Registry updated 2024-05-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study) | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 / Phase 2 | 2024-05-09 | NCT06002659 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Elicera Therapeutics | 1 |
| Karolinska University Hospital | 181 |
| Uppsala University | 156 |
| Uppsala University Hospital | 80 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Karolinska University Hospital | Stockholm | Sweden | 87 |
| Uppsala University Hospital | Uppsala | Sweden | 50 |